3 results about "Alpha-Tocopherol" patented technology

The disclosure relates to an oral composition comprising an active ingredient consisting essentially of alpha tocotrienol, gamma tocotrienol, delta tocotrienol, alpha tocopherol and phospholipid in specific percentages for use in liver health optimization. The compositions are stable at room temperature & accelerated storage conditions.

The application provides a natural vitamin E purification method. The purification method comprises the following steps: S1, dissolving natural vitamin E in anhydrous ethanol to obtain a vitamin E solution; S2, adding an antioxidant to the vitamin E solution, and then slowly adding a potassium hydroxide solution to perform a saponification reaction to obtain a mixed solution; S3, performing acid neutralization, salt water washing, liquid cyclone separation and dehydration on the mixed solution to obtain crude vitamin E oil; and S4, performing falling film evaporation and short path molecular distillation on the crude vitamin E oil to obtain high-purity natural vitamin E. Through process optimization of a traditional purification process, the process of low-temperature saponification combined with salt water washing and molecular distillation after thin film evaporation is adopted, no residual plasticizer is detected in the purified vitamin E, the content of total tocopherol is higher than 95%, and the proportion of d-alpha tocopherol with high activity in the total tocopherol is more than 50%.

Disclosed is a method and composition for treating non-cirrhotic NASH. A first embodiment of the invention is the administration of a twice daily oral dose of approximately 117-400 mg testosterone equivalent to a subject having liver fibrosis. A second embodiment of the invention is the administration of a once or twice daily oral dose of approximately 117-400 mg testosterone equivalent formulated with approximately 200-600 mg of d-alpha tocopherol equivalent to a subject having liver fibrosis.